Alaunos Therapeutics's total assets for Q1 2026 were $1.88M, a decrease of -36.51% from the previous quarter. TCRT total liabilities were $595.00K for the fiscal quarter, a -26.81% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.